<!DOCTYPE html>
<html>

<head>
    <title>Page 106</title>
</head>

<body>

    <h4 style="color: blue; text-decoration: underline; margin: 0;">Patients with rental impairment</h4>
    <ul>
        <li>No dose reduction is required in patients
            with impaired renal function as long as
            hepatic function is not impaired.</li>
        <li>Only in cases of creatinine clearance < 10 ml/min, ceftriaxone dosage shouldnâ€™t not exceed 2 g daily.</li>
        <li>In patients undergoing dialysis no
            additional supplementary dosing is
            required following the dialysis.</li>
        <li>In patients with both severe renal and
            hepatic dysfunction, close clinical
            monitoring for safety and efficacy is
            advised.</li>
    </ul>

</body>

</html>